Marksans Pharma Limited has informed the Exchange about Copy of Newspaper Publication
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has submitted copies of newspaper advertisements published in Business Standard (English) and Lakshadeep (Marathi) on August 23, 2025, notifying shareholders about the upcoming transfer of unclaimed dividends and corresponding equity shares to the Investor Education and Protection Fund (IEPF). The filing was made under Regulation 47 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Shareholders whose dividends have remained unclaimed for seven consecutive years are at risk of having their shares transferred to the IEPF. The intimation was signed by Company Secretary Harshavardhan Panigrahi on August 25, 2025.
This is a routine regulatory compliance filing with no direct impact on the stock price. However, shareholders with unclaimed dividends from Marksans Pharma should act promptly to claim them and update their KYC details to avoid losing their shares to the IEPF.